Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. A randomised phase III study on capecitabine, oxaliplatin and bevacizumab with or without cetuximab in first-line advanced colorectal cancer, the CAIRO2 study of the Dutch Colorectal Cancer Group (DCCG). An interim analysis of toxicity 5. Medicare pay-for-reporting effort draws fire from frustrated doctors
Your Article Summary
See Latest ArticlesClinical trial: intragastric acid control in patients who have Barrett's oesophagus-comparison of once- and twice-daily regimens of esomeprazole and lansoprazole
Alimentary Pharmacology and Therapeutics, 07/01/09
Spechler SJ et al. - Esomeprazole 40 mg is significantly more effective than lansoprazole 30 mg in controlling intragastric pH with Barrett's oesophagus.
Related Articles
Grading of gastric foveolar-type dysplasia in Barrett's esophagus
Modern Pathology, 10/23/09
Relevance Score: 45%
"Glassy" Cells in Barrett's Mucosa
Anticancer Research, 11/11/09
Relevance Score: 44%
Prevalence of Barrett's Esophagus Remains Low in the Korean Population: Nationwide Cross-Sectional Prospective Multicenter Study
Digestive Diseases and Sciences, 10/06/09
Relevance Score: 42%
Imaging of subsquamous Barretts epithelium with ultrahigh-resolution optical coherence tomography: a histologic correlation study
Gastrointestinal Endoscopy, 10/23/09
Relevance Score: 40%
Radiofrequency Ablation of Barrett's Esophagus
Journal of Gastrointestinal Surgery, 10/13/09
Relevance Score: 40%
Today in Esophagus...keeping you current
Receive free subspecialty "5-minute updates" via email
Clinical implications of esophagorespiratory fistulae in patients with esophageal squamous cell carcinoma (SCCA)
Medical Oncology, 12/04/09
Association of C-Reactive Protein Levels and Long-Term Survival after Neoadjuvant Therapy and Esophagectomy for Esophageal Cancer
Journal of Gastrointestinal Surgery, 12/03/09
p53 Genotype Predicts Response to Chemotherapy in Patients with Squamous Cell Carcinoma of the Esophagus
Annals of Surgical Oncology, 12/02/09
Today in Pharmacology/kinetics...keeping you current
Receive free subspecialty "5-minute updates" via email
ML17032 trial: capecitabine/cisplatin versus 5-fluorouracil/cisplatin as first-line therapy in advanced gastric cancer
Expert Review of Anticancer Therapy, 12/04/09
Bevacizumab combined with chemotherapy for patients with advanced colorectal cancer: a systematic review
Annals of Oncology, 12/04/09
A phase I study of axitinib (AG-013736) in combination with bevacizumab plus chemotherapy or chemotherapy alone in patients with metastatic colorectal cancer and other solid tumors
Annals of Oncology, 12/04/09
Sponsor
Article Search
Sponsor